28 articles for D Ekinci
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.

Jamia Hamdard (Hamdard University)
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.

Balikesir University
Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives.

Gebze Technical University
Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives.

Agriibrahim£E£En University
Synthesis of 1,4-bis(indolin-1-ylmethyl)benzene derivatives and their structure-activity relationships for the interaction of human carbonic anhydrase isoforms I and II.

Karamanoglu Mehmetbey University
Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity.

Agri Ibrahim Cecen University
Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors.

Batman University
Characterization and anions inhibition studies of ana-carbonic anhydrase from the teleost fish Dicentrarchus labrax.

Ondokuz Mayis University
In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates.

Ataturk University
Structure-activity relationships for the interaction of 5,10-dihydroindeno[1,2-b]indole derivatives with human and bovine carbonic anhydrase isoforms I, II, III, IV and VI.

Ondokuz Mayis University
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.

University of Calgary
A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.

Ataturk University
NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and II.

Ataturk University
Dihydrofolate reductase inhibitors

Trius Therapeutics
Pyrazoloquinolines

Merck Patent
Apoptosis signal-regulating kinase 1 inhibitors

Takeda Pharmaceutical
Synthesis of (glycopyranosyl-triazolyl)-purines and their inhibitory activities against protein tyrosine phosphatase 1B (PTP1B).

East China University of Science and Technology
5-lipoxygenase-activating protein inhibitor

Panmira Pharmaceuticals
Amine substituted methanesulfonamide derivatives as vanilloid receptor ligands

Gruenenthal
PDE10 modulators

Hoffmann-La Roche
Fused 2-aminothiazole compounds

Dana-Farber Cancer Institute
Synthesis and evaluation of novel marine bromopyrrole alkaloid-based derivatives as potential antidepressant agents.

University of Kwazulu-Natal
Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.

Y.B. Chavan College of Pharmacy
7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof

Theron Pharmaceuticals
Inhibitors of PI3 kinase

Amgen
Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models.

Abbott Laboratories